Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Cochlioquinone A, a bioactive compound isolated from D. sacchari and Bipolaris sp., is an inhibitor of diacylglycerol kinase (DGK; Ki = 3.1 µM) and diacylglycerol acyltransferase (DGAT; IC50 = 5.6 µM).1,2,3 It has been shown to reduce the concentration of phosphatidic acid in T cell lymphoma with an IC50 value of 3 µM.1 It is also reported to compete with macrophage inflammatory protein-1α for binding to human CCR5 chemokine receptors with an IC50 value of 11 µM.3
WARNING This product is not for human or veterinary use.
1. Cochlioquinone A, an inhibitor of diacylglycerol kinase. J. Antibiot. (Tokyo) 48(10), 1076-1080 (1995).
2. Inhibitory activity of diacylglycerol acyltransferase by cochlioquinones A and A1. J. Antibiot. (Tokyo) 56(11), 967-969 (2003).
3. Cochlioquinones and epi-